NeuroPace, Inc. NPCE
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.05% | 20.45% | 23.86% | 29.89% | 1.27% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.05% | 20.45% | 23.86% | 29.89% | 1.27% |
| Cost of Revenue | 19.22% | 26.02% | 13.87% | 9.68% | -35.81% |
| Gross Profit | 16.61% | 19.28% | 27.12% | 37.28% | 14.71% |
| SG&A Expenses | -2.31% | 13.67% | 11.07% | 23.60% | 22.78% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.01% | 10.19% | 12.88% | 18.38% | 8.65% |
| Operating Income | 37.20% | 17.63% | 51.63% | 38.72% | -31.44% |
| Income Before Tax | 38.10% | 18.45% | 48.02% | 35.88% | -33.30% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 38.10% | 18.45% | 48.02% | 35.88% | -33.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.33% | -1.52% | 48.02% | 35.88% | -15.13% |
| EBIT | 37.20% | 17.63% | 51.63% | 38.72% | -31.44% |
| EBITDA | 37.58% | 17.93% | 53.20% | 39.19% | -31.79% |
| EPS Basic | 30.93% | 5.21% | 53.45% | 43.03% | -1.08% |
| Normalized Basic EPS | 37.24% | 28.20% | 54.67% | 43.04% | -11.18% |
| EPS Diluted | 30.93% | 5.21% | 53.45% | 43.03% | -1.08% |
| Normalized Diluted EPS | 37.24% | 28.20% | 54.67% | 43.04% | -11.18% |
| Average Basic Shares Outstanding | 3.78% | 7.08% | 11.60% | 12.53% | 13.90% |
| Average Diluted Shares Outstanding | 3.78% | 7.08% | 11.60% | 12.53% | 13.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |